Daniela Laimer
Medical University of Vienna
9 Papers
8 Citations
Daniela Laimer is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Anaplastic large-cell lymphoma & Lymphoma. The author has an hindex of 6, co-authored 9 publications. Previous affiliations of Daniela Laimer include University of Vienna.
Chat about Author
Papers
Coronary Neutrophil Extracellular Trap Burden and Deoxyribonuclease Activity in ST-Elevation Acute Coronary Syndrome Are Predictors of ST-Segment Resolution and Infarct Size
Andreas Mangold,Sherin Alias,T Scherz,Thomas M. Hofbauer,Johannes Jakowitsch,Adelheid Panzenböck,Daniel Simon,Daniela Laimer,Christine Bangert,Andreas A. Kammerlander,Julia Mascherbauer,Max-Paul Winter,Klaus Distelmaier,Christopher Adlbrecht,Klaus T. Preissner,Irene M. Lang +15 more
TL;DR: PMNs are highly activated in ST-elevation acute coronary syndrome and undergo NETosis at the CLS, andCoronary NET burden and deoxyribonuclease activity are predictors of ST-segment resolution and myocardial infarct size.
455
Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction.
Julia Mascherbauer,Beatrice A. Marzluf,Caroline Tufaro,Stefan Pfaffenberger,Alexandra Graf,Paul Wexberg,Adelheid Panzenböck,Johannes Jakowitsch,Christine Bangert,Daniela Laimer,Catharina Schreiber,Gültekin Karakus,Martin Hülsmann,Richard Pacher,Irene M. Lang,Gerald Maurer,Diana Bonderman +16 more
TL;DR: In the present preliminary study, cardiac magnetic resonance postcont contrast T1 time is associated with prognosis in HFPEF, suggesting postcontrast T1 as possible biomarker for HFP EF.
169
The dichloromethane extract of the ethnomedicinal plant Neurolaena lobata inhibits NPM/ALK expression which is causal for anaplastic large cell lymphomagenesis.
Christine Unger,Ruxandra Popescu,Benedikt Giessrigl,Daniela Laimer,Susanne Heider,Mareike Seelinger,Rene Diaz,Bruno Wallnöfer,Gerda Egger,Melanie R. Hassler,Martin Knöfler,Leila Saleh,Emine Sahin,Michael Grusch,Monika Fritzer-Szekeres,Helmut Dolznig,Richard Frisch,Lukas Kenner,Brigitte Kopp,Georg Krupitza +19 more
TL;DR: It is shown that a traditional healing plant extract, an anti-protozoan plant of the Maya, downregulates various oncogenes, induces tumor suppressors, inhibits cell proliferation, and triggers apoptosis of malignant cells.
New and Highly Efficient Therapy for Treatment NPM-ALK Associated Lymphomas
Lukas Kenner,Daniela Laimer,Helmut Dolznig,Paul Vesely,Karoline Kollmann,Ana-Iris Schiefer,Veronika Sexl,Philipp B. Staber,Gerald Hoefler,Josef M. Penninger,Giorgio Inghirami,Jaeger Ulrich +11 more
TL;DR: The data for the first time unravel a highly effective targeted therapy with the outlook to make ALCL a curable disease and certify the PDGFRB as a novel cJun/JunB target essential for ALCL development.
1
Patent
Methods involving pdgfrbeta inhibitors
Lukas Kenner,Daniela Laimer +1 more
- 28 Sep 2010
TL;DR: In this paper, the PDGFRbeta inhibitor was used in the antiproliferative treatment of T-cell lymphoma, in particular NHL, ALCL and PTCL.